BIO-RAD LABORATORIES -CL B (BIO.B) Stock Earnings & Estimates
USA - NYSE:BIO.B - US0905721082 - Common Stock
247.05 USD
-10.7 (-4.15%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.802B -4.12% | 2.671B -4.67% | 2.567B -3.92% | 2.547B -0.76% | 2.634B 3.42% | 2.745B 4.21% | 2.725B -0.73% | 2.785B 2.20% | |
| EBITDA YoY % growth | N/A -13.40% | N/A -19.14% | N/A -8.95% | 418.06M -11.60% | 462.84M 10.71% | 502.06M 8.47% | 434.43M -13.47% | 465.96M 7.26% | |
| EBIT YoY % growth | 486.8M -13.79% | 366M -24.82% | 299M -18.31% | 277.58M -7.16% | 322.52M 16.19% | 360.18M 11.68% | 531.26M 47.50% | N/A | |
| Operating Margin | 17.37% | 13.70% | 11.65% | 10.90% | 12.24% | 13.12% | 19.50% | N/A | |
| EPS YoY % growth | 14.23 -9.19% | 11.77 -17.29% | 10.31 -12.40% | 8.52 -17.35% | 9.37 9.95% | 10.78 15.07% | 8.21 -23.84% | 8.26 0.62% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.69 -16.12% | 2.71 -6.69% | 2.42 -4.63% | 3.04 16.48% | 2.92 72.92% | 3.19 17.82% | 2.26 -6.60% | 2.63 -13.62% | 3.05 4.62% | 3.65 14.36% |
| Revenue Q2Q % growth | 638.84M -1.68% | 690.03M 3.38% | 612.5M 4.63% | 665.93M 2.20% | 690.83M 8.14% | 721.07M 4.50% | 619.07M 1.07% | 676.43M 1.58% | 697.41M 0.95% | 734.21M 1.82% |
| EBITDA Q2Q % growth | 93.492M 29.90% | 127.93M -4.47% | 110M 31.03% | 129.76M 36.80% | 139.25M 48.94% | 151.57M 18.48% | 92.708M -15.72% | 123.41M -4.89% | 137.92M -0.96% | 159.19M 5.03% |
| EBIT Q2Q % growth | 59.349M -36.86% | 93.394M 61.02% | 71.366M 25.20% | 93.637M 54.02% | 102.78M 73.18% | 114.64M 22.75% | 55.712M -21.93% | 86.587M -7.53% | 100.78M -1.95% | 121.51M 5.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.61 -16.08% | 1.75 | 0.86 | 49.07% |
| Q1 2025 Q2Q % growth | 2.54 10.92% | 1.83 | 0.71 | 38.97% |
| Q4 2024 Q2Q % growth | 2.90 -6.45% | 2.90 | 0.00 | 0.10% |
| Q3 2024 Q2Q % growth | 2.01 -13.73% | 1.17 | 0.84 | 72.05% |
| Q2 2024 Q2Q % growth | 3.11 3.67% | 2.03 | 1.08 | 52.84% |
| Q1 2024 Q2Q % growth | 2.29 -31.44% | 2.17 | 0.12 | 5.67% |
| Q4 2023 Q2Q % growth | 3.10 -6.34% | 2.85 | 0.25 | 8.96% |
| Q3 2023 Q2Q % growth | 2.33 -10.38% | 2.81 | -0.48 | -17.09% |
| Q2 2023 Q2Q % growth | 3.00 -11.24% | 2.71 | 0.29 | 10.88% |
| Q1 2023 Q2Q % growth | 3.34 -32.39% | 3.58 | -0.24 | -6.64% |
| Q4 2022 Q2Q % growth | 3.31 3.12% | 3.48 | -0.17 | -4.96% |
| Q3 2022 Q2Q % growth | 2.60 -29.92% | 2.81 | -0.21 | -7.47% |
| Q2 2022 Q2Q % growth | 3.38 -4.52% | 2.83 | 0.55 | 19.58% |
| Q1 2022 Q2Q % growth | 4.94 -5.18% | 3.44 | 1.50 | 43.76% |
| Q4 2021 Q2Q % growth | 3.21 -19.95% | 2.88 | 0.33 | 11.49% |
| Q3 2021 Q2Q % growth | 3.71 23.67% | 2.46 | 1.25 | 50.71% |
| Q2 2021 Q2Q % growth | 3.54 119.88% | 2.69 | 0.85 | 31.54% |
| Q1 2021 Q2Q % growth | 5.21 172.77% | 3.03 | 2.18 | 72.12% |
| Q4 2020 Q2Q % growth | 4.01 72.84% | 3.33 | 0.68 | 20.49% |
| Q3 2020 Q2Q % growth | 3.00 86.34% | 1.82 | 1.18 | 64.86% |
| Q2 2020 Q2Q % growth | 1.61 8.05% | 1.24 | 0.37 | 30.31% |
| Q1 2020 Q2Q % growth | 1.91 15.76% | 1.58 | 0.33 | 20.84% |
| Q4 2019 Q2Q % growth | 2.32 | 2.47 | -0.15 | -6.05% |
| Q3 2019 Q2Q % growth | 1.61 | 1.42 | 0.19 | 13.46% |
| Q2 2019 Q2Q % growth | 1.49 | 1.35 | 0.14 | 10.51% |
| Q1 2019 Q2Q % growth | 1.65 | 1.12 | 0.53 | 47.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 651.6M 2.06% | 621.36M | 30.24M | 4.87% |
| Q1 2025 Q2Q % growth | 585.4M -4.16% | 579M | 6.4M | 1.11% |
| Q4 2024 Q2Q % growth | 667.5M -2.01% | 686.09M | -18.59M | -2.71% |
| Q3 2024 Q2Q % growth | 649.729M 2.79% | 634.46M | 15.269M | 2.41% |
| Q2 2024 Q2Q % growth | 638.476M -6.26% | 652.25M | -13.774M | -2.11% |
| Q1 2024 Q2Q % growth | 610.82M -9.75% | 625.28M | -14.46M | -2.31% |
| Q4 2023 Q2Q % growth | 681.184M -6.73% | 691.94M | -10.756M | -1.55% |
| Q3 2023 Q2Q % growth | 632.1M -7.15% | 696.46M | -64.36M | -9.24% |
| Q2 2023 Q2Q % growth | 681.11M -1.45% | 704.94M | -23.83M | -3.38% |
| Q1 2023 Q2Q % growth | 676.844M -3.32% | 696.73M | -19.886M | -2.85% |
| Q4 2022 Q2Q % growth | 730.3M -0.34% | 749.67M | -19.37M | -2.58% |
| Q3 2022 Q2Q % growth | 680.8M -8.86% | 686.74M | -5.94M | -0.86% |
| Q2 2022 Q2Q % growth | 691.1M -3.46% | 689.45M | 1.65M | 0.24% |
| Q1 2022 Q2Q % growth | 700.1M -3.67% | 681.85M | 18.25M | 2.68% |
| Q4 2021 Q2Q % growth | 732.8M -7.22% | 739.3M | -6.5M | -0.88% |
| Q3 2021 Q2Q % growth | 747M 15.40% | 668.49M | 78.51M | 11.74% |
| Q2 2021 Q2Q % growth | 715.9M 33.34% | 638.1M | 77.8M | 12.19% |
| Q1 2021 Q2Q % growth | 726.8M 27.15% | 667.59M | 59.21M | 8.87% |
| Q4 2020 Q2Q % growth | 789.8M 26.49% | 693.67M | 96.13M | 13.86% |
| Q3 2020 Q2Q % growth | 647.3M 15.47% | 576.28M | 71.02M | 12.32% |
| Q2 2020 Q2Q % growth | 536.9M -6.23% | 522.22M | 14.68M | 2.81% |
| Q1 2020 Q2Q % growth | 571.6M 3.18% | 552.32M | 19.28M | 3.49% |
| Q4 2019 Q2Q % growth | 624.4M | 648.37M | -23.97M | -3.70% |
| Q3 2019 Q2Q % growth | 560.6M | 570.69M | -10.09M | -1.77% |
| Q2 2019 Q2Q % growth | 572.6M | 571.86M | 740K | 0.13% |
| Q1 2019 Q2Q % growth | 554M | 555.05M | -1.05M | -0.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.36% | -30.61% | -2.06% | -12.45% |
| Revenue | -0.05% | -3.11% | -0.08% | -1.58% |